Enhancement of attentional processing is attained by administration of an endorphinase inhibitor or enkephalinase inhibitor and optionally, a dopamine precursor, or a serotonin precursor, a GABA precursor, or an endorphin or enkephalinase releaser, or certain herbal compounds including Rhodiola rosea extract (Pharmaline) and/or Huperzine. These components promote restoration of normal neurotransmitter function and the components combined enhance the release of dopamine at the nucleus accumbens and are non-addictive. Use of the dopamine precursors L-phenylalanine, or L-Tyrosine, the enkephalinase inhibitor D-phenylalanine, and/or the serotonin precursor -hydroxytryptophan and a natural acetylcholenesterase inhibitor and chromium salts (i.e. picolinate, nicotinate, etc.) is especially preferred, but not limited to assist in relieving symptoms associated with brain phenylalanine deficiency.
Source: Patent WO1998048785A9 – Allelic polygene diagnosis of reward deficiency syndrome and treatment – Google Patents
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/searchresults/”]
[tubepress enableQuickplay=”true” theme=”tubepress/legacy-quickplay” mode=”tag” tagValue=”deficiency” playerLocation=”popup” resultsPerPage=”10″ autoPlay=”false” thumbHeight=”514″ thumbWidth=”625″ responsiveEmbeds=”false” paginationBelow=”false”]
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/searchresults/”]
